{"nct_id":"NCT02652260","title":"Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028)","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2016-03-04","start_date_type":"ACTUAL","primary_completion_date":"2018-08-14","primary_completion_date_type":"ACTUAL","completion_date":"2024-02-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}